1.Schmid-Grendelmeier P., Simon D., Simon P. et al. Epidemiology, clinical features, and immunology of the "intrinsic" (non-IgE mediated) type of atopic dermatitis (constitutional dermatitis). Allergy 2001; 56: 841—849.2.Wüthrich B., Cozzio A., Roll A. et al. Atopic eczema: genetics or environment? Ann Agric Environ Med 2007: 14: 195—201.3.Wüthrich B., Schmid-Grendelmeier P. The atopic eczema/dermatitis syndrome. Epidemiology, natural course, and immunology of the "IgE-associated ("extrinsic") and the nonallergic ("intrinsic") AEDS. J Investig Allergol Clin Immunol 2003; 13: 1—5.4.Nestle F.Q., Kaplan D.H., Barker J. Psoriasis. N Engl J Med 2009; 361: 469—509.5.Prignano F., Ricceri F., Pescitelli L., Lotti T. Itch in psoriasis: epidemiology, clinical aspects and treatment options. Clin Cosmet Investig Dermatol 2009; 2: 9—13.6.Reich A., Hrehorow E., Szepietowski J.C. Pruritus is an important factor negatively influencing the well-being of psoriatic patients. Acta Derm Venereol 2010; 90: 257—263.7.O’Neill J.L., Chan Y.H., Rapp S.R., Yosipovitch G. Differences in itch characteristics between psoriasis and atopic dermatitis patients: results of a web-based questionnaire. Acta Derm Venereol 2011; 91: 537—540.8.Schon M.P., Boehncke W.H. Psoriasis. N Engl J Med 2005; 352: 1899—1912.9.Bieber T. Atopic dermatitis. Ann Dermatol 2010; 22: 125—137.10.Nickoloff B.J., Xin H., Nestle F.O., Qin J.Z. The cytokine and chemokine network in psoriasis. Clin Dermatol 2007; 25: 568—573.11.Yamanaka K., Mizutani H. The role of cytokines/chemokines in the pathogenesis of atopic dermatitis. Curr Probl Dermatol 2011; 41: 80—82.12.Johnson-Huang L.M., Lowes M.A., Krueger J.G. Putting together the psoriasis puzzle: an update on developing targeted therapies. Diseases Models & Mechanisms 2012; 5: 423—433. Литература13.Shepherd A.J., Downing J.E.G., Miyan J.A. Without nerves, immunology remains incomplete — in vivo veritas. Immunology 2005; 116: 145—163.14.Tausk F., Elenkov I., Moynihan J. Psychoneuroimmunology. Dermatol Ther 2008; 21: 22—31.15.Jarvikallio A., Harvima I.T., Naukkarinen A. Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema. Arch Dermatol Res 2003; 295: 2—7.16.Raap U., Kapp A. Neuroimmunological findings in allergic skin diseases. Curr Opin Allergy Clin Immunol 2005; 5: 419—424.17.Buddenkotte J., Steinhoff M. Pathophysiology and therapy of pruritus in allergic and atopic diseases. Allergy 2010; 65: 805—821.18.Potenzieri C., Undem B.J. Basic mechanisms of itch. Clin Exp Allergy 2012; 42 (1): 8—19.19.Schmelz M., Schmidt R., Bickel A. et al. Specific C-receptors for itch in human skin. J Neurosci 1997; 17: 8003—8008.20.Toyoda M., Nakamura M., Makino T. et al. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 2002; 147: 71—79.21.Masahiko T. Useful therapeutic markers of atopic dermatitis: neurogenic factors. Skin Research 2005; 4 (Suppl 5): 87—93.22.Dou Y.C., Hagströmer L., Emtestam L., Johansson O. Increased nerve growth factor and its receptors in atopic dermatitis: an immunohisto-chemical study. Arch Dermatol Res 2006; 298: 31—37.23.Kleyn C.E., Schneider L., Saraceno R. et al. The effects of acute social stress on epidermal Langerhans’ cell frequency and expression of cutaneous neuropeptides. J Invest Dermatol 2008; 128: 1273—1279.24.Botchkarev V.A., Eichmüller S., Peters E.M.J. et al. A simple immunofluorescence technique for simultaneous visualization of mast cells and nerve fibers reveals selectivity and hair cycle-dependent changes in mast cell-nerve fiber contacts in murine skin. Arch Dermatol Res 1997; 289: 292—302.25.Hodeib A., El-Samad Z.A., Hanafy H. et al. Nerve growth factor, neuropeptides and cutaneous nerves in atopic dermatitis. Indian J Dermatol 2010; 55 (2): 135—139.26.Tominaga M., Ozawa S., Tengara S. et al. Intraepidermal nerve fibers increase in dry skin of acetone-treated mice. J Dermatol Sci 2007; 48 (2): 103—111.27.Besedovsky H., del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev 1996; 17: 64—102.28.Pincelli C., Marconi A. Autocrine nerve growth factor in human keratinocytes. J Dermatol Sci 2000; 22: 71—79.29.Slominski A., Wortsman J. Neuroendocrinology of the skin. Endocr Rev 2000; 21: 457—487.30.Arck P.C., Slominski A., Theoharides T.C. et al. Neuroimmunology of stress: skin takes center stage. J Invest Dermatol 2006; 126: 1697—1704.31.Botchkarev V.A., Yaar M., Peters E.M. et al. Neurotrophins in skin biology and pathology. J Invest Dermatol 2006; 126: 1719—1727.32.Harvima I.T., Nilsson G., Naukkarinen A. Role of mast cells and sensory nerves in skin inflammation. G Ital Dermatol Venereol 2010; 145: 195—204.33.Miyazaki Y., Satoh T., Nishioka K., Yokozeki H. STAT-6-mediated control of P-selectin by substance P and interleukin-4 in human dermal endothelial cells. Am J Pathol 2006; 169 (2): 697—707.34.Quinlan K.L., Song I.-S., Bunnett N.W. et al. Neuropeptide regulation of human dermal microvascular endothelial cell ICAM-1 expression and function. Am J Physiol — Cell Physiol 1998; 275: C1580—1590.35.Quinlan K.L., Song I.-S., Naik S.M. et al. VCAM-1 expression on human dermal micro-vascular endothelial cells is directly and specifically up-regulated by Substance P. J Immunol 1999; 162: 1656—1661.36.Viac J., Gueniche A., Doutremepuich J.D. et al. Substance P and keratinocyte activation markers: an in vitro approach. Arch Dermatol Res 1996; 288: 85—90.37.Church M.K., el-Lati S., Caulfield J.P. Neuropeptide-induced secretion from human skin mast cells. Int Arch Allergy Appl Immunol 1991; 94: 310—318.38.Ansel J.C., Brown J.R., Payan D.G., Brown M.A. Substance P selectively activates TNF-alpha gene expression in murine mast cells. J Immunol 1993; 150: 4478—4485.39.Roosterman D., Goerge T., Schneider S.W. et al. Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol Rev 2006; 86: 1309—1379.40.Hosoi J., Murphy G.F., Egan C.L. et al. Regulation of Langerhans’ cell function by nerves containing calcitonin gene-related peptide. Nature 1993; 363: 159—163.41.Asahina A., Moro O., Hosoi J. et al. Specific induction of cAMP in Langerhans’ cells by calcitonin gene-related peptide: relevance to functional effects. Proc Natl Acad Sci USA 1995; 92: 8323—8327.42.Ding W., Stohl L., Wagner J.A. et al. Calcitonin gene-related peptide biases Langerhans cells towards Th2-type immunity. J Immunol 2008; 181 (9); 6020—6026.43.Blennerhassett M.G., Tomioka M., Bienenstock J. Formation of contacts between mast cells and sympathetic neurons in vitro. Cell Tissue Res 1991; 265: 121—128.44.Foster E.L., Simpson E.L., Fredrikson L.J. et al. Eosiniphils increase neuron branching in human and murine sin in vitro. PLoS ONE 2011; 6 (7): e22029.45.Altmayr F., Jusek G., Holzmann B. The neuropeptide calcitonin gene-related peptide causes repression of tumor necrosis factor-transcription and suppression of ATF-2 promoter recruitment in toll-like receptor-stimulated dendritic cells. J Biol Chem 2010; 285 (6): 3525—3531.46.de Mel S., Nordlind K., Holst M. et al. Polymorphisms in the serotonin transporter gene of patients with atopic dermatitis-association with personality traits related to high level of anxiety. Immunopharmacol Immunotoxicol 2012; 34 (3): 534—538.47.Suto H., Matsuda H., Mitsuishi K et al. NC/Nga mice: a mouse model for atopic dermatitis. Int Arch Allergy Immunol 1999; 120: 70—75.48.Vestergaard C., Yoneyama H., Matsishima K. The NC/Nga mouse: a model of atopic dermatitis. Mol Med Today 2000; 6: 209—210.49.Matsuda H., Watanabe N., Geba G.P. et al. Development of atopic dermatitis-like skin lesion with IgE-hyperproduction in NC/Nga mice. Int Immunol 1997; 9: 461—466.50.Takubo M., Ueda Y., Yatsuzuka R. et al. Characteristics of scratching behavior induced by some chemical mediators in hairless mice. J Pharmacol Sci 2006; 100: 285—288.51.Ohmura T., Hayashi T., Satoh Y. et al. Involvement of substance P in scratching behaviour in an atopic dermatitis model. Eur J Pharmacol 2004; 491 (2-3): 191—194.52.Fortune D.G., Richards H.L., Griffiths C.E. Psychologic factors in psoriasis: consequences, mechanisms, and interventions. Dermatol Clin 2005; 23: 681—694.53.Hashizume H., Horibe T., Ohshima A. et al. Anxiety accelerates T-helper 2-tilted immune responses in patients with atopic dermatitis. Br J Dermatol. 2005;152 (6): 1161—1164.54.Liezmann C., Klapp B., Peters E.M.J. Stress, atopy and allergy. A re-evaluation from psycho-neuroimmunologic perspective. Dermatoendocrinol 2011; 3: 37—40.55.Rasul A., El-Nour H., Blakely R.D. et al. Effect of chronic mild stress on serotoninergic markers in the skin and brain of the NC/Nga atopic-like mouse strain. Arch Dermatol Res 2011; 303 (9): 625—633.56.Albers K.M., Wright D.E., Davis B.M. Overexpression of nerve growth factor in epidermis of transgenic mice causes hypertrophy of the peripheral nervous system. J Neurosci 1994; 14: 1422—1432.57.Crowley C., Spencer S.D., Nishimura M.C. et al. Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell 1994; 76: 1001—1011.58.Tominaga M., Ozawa S., Ogawa H., Takamori K. A hypothetical mechanism of intraepidermal neurite formation in NC/Nga mice with atopic dermatitis. J Dermatol Sci 2007; 46: 199—210.59.Tominaga M., Kamo A., Tengara S. et al. In vitro model for penetration of sensory nerve fibres on a Matrigel basement membrane: implications for possible application to intractable pruritus. Br J Dermatol 2009; 161: 1028—1037.60.Fujisawa H. Discovery of semaphoring receptors, neutropilin and plexin, and their functions in neural development. J Neurobiol 2004; 59: 24—33.61.Nakamura F., Kalb R.G., Strittmatter S.M. Molecular basis of semaphorin-mediated axon guidance. J Neurobiol 2000; 44: 219—229.62.Chang S.E., Han S.S., Jung H.J., Choi J.H. Neuropeptides and their receptors in psoriatic skin in relation to pruritus. Br J Dermatol 2007; 156: 1272—1277.63.Ikoma A. Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment: mechanisms and management of itch in atopic dermatitis. J Pharmacol Sci 2009; 110: 265—269.64.Sugiura H., Omoto M., Hirota Y. et al. Density and fine structure of peripheral nerves in various skin lesions of atopic dermatitis. Arch Dermatol Res 1997; 289: 125—131.65.Szepietowski J.C., Reich A., Wiśnicka B. Itching in patients suffering from psoriasis. Acta Dermatovenerol Croat 2002; 10: 221—226.66.El-Nour H., Santos A., Nordin M. et al. Neuronal changes in psoriasis exacerbation. J Eur Acad Dermatol Venereol 2009; 23 (11): 1240—1245.67.Kawana S., Kato Y., Omi T. Efficacy of a 5-HT1a receptor agonist in atopic dermatitis. Clin Exp Dermatol 2010; 35 (8): 835—840.68.Zylicz Z., Krajnik M., Sorge A.A., Costantini M. Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial. J Pain Symptom Manage 2003; 26: 1105—1112.69.Zylicz Z., Smits C., Krajnik M. Paroxetine for pruritus in advanced cancer. J Pain Symptom Manage 1998; 16: 121—124.70.Browning J., Combes B., Mayo M.J. Long-term efficacy of sertraline as a treatment for cholestatic pruritus in patients with primary biliary cirrhosis. Am J Gastroenterol 2003; 98: 2736—2741.71.Tefferi A., Fonseca R. Selective serotonin reuptake inhibitors are effective in the treatment of polycythemia vera-associated pruritus. Blood 2002; 99: 2627.72.Duval A., Dubertret L. Aprepitant as an antipruritic agent? N Engl J Med 2009; 361: 1415— 1416.73.Ständer S., Siepmann D., Herrgott I. et al. Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy. PLoS One 2010; 5: e10968.